Daewoong Pharm to jump into domestic anticancer market
Published: 2004-03-18 06:58:00
Updated: 2004-03-18 06:58:00
Daewoong Pharm said on March 15 that it signed an exclusive agreement with U.K.-based BiolitecAG for the distribution of Foscan, which is a photosensitizing agent containing temoporfin and is used in photodynamic therapy (PDT). It added that in the latter half of this year, Daewoong will roll out...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.